NCT07349602

Brief Summary

Non-specific spondylodiscitis is a bacterial infection of the spine that in some cases requires surgical treatment. The basis of surgical treatment is the removal of affected tissues. In this case, the supportive function of the affected area is lost, which also requires stable fixation. Access to the affected part of the spine can be achieved through both anterior and posterior approaches. There is no reliable data yet confirming the advantages of each approach. Our study demonstrated successful surgical treatment of infection foci using posterior approach, no neurological or other complications were occurred. Older patients shown differences in hemoglobin levels, postoperative pain scores, the number of affected vertebrae, types of bacteria and recurrent rate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

November 26, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

4 years

First QC Date

November 26, 2025

Last Update Submit

January 21, 2026

Conditions

Keywords

pyogenicSpondylodiscitisposterior approachmicrobiological profiles

Outcome Measures

Primary Outcomes (12)

  • Surgery time

    Surgery time in minutes

    From enrollment to the end of surgery at 1 year

  • Hospital stays

    Hospital stays in day

    From enrollment to the end of surgery at 1 year

  • Re-operation

    Re-operation number

    From enrollment to the 1-year post-surgical treatment follow-up period

  • Health Questionnaire EuroQol 5 Dimension five levels (EQ-5D-5L)

    The EQ-5D-5L descriptive system uses five dimensions and five levels of severity in each dimension. TThe five dimensions include mobility, self-care, activities of daily living, pain and discomfort, and anxiety and depression. The five levels in each dimension are worded as (1) 'not /no problems', (2) 'slight problems', (3) 'moderate problems', (4) 'severe problems' and (5) 'unable to' (mobility, self-care, usual activities), 'extreme' (pain/depression), or 'extremely' (anxiety/depression). Their responses are coded as a number (1, 2, 3, 4 or 5) that corresponds to the respective level of severity: 1 indicates no problems, 2-4 some problems and 3 extreme problems. In this way, a person's health state profile can be defined by a 5-digit number, ranging from 11111 (having no problems in any of the dimensions) to 55555 (having extreme problems in all the dimensions). The assigning of a value to an EQ-5D state is based on the time trade-off (TTO) approach.

    From enrollment to the end of surgery at 1 year

  • VAS-pain after surgery

    VAS-pain on the 2nd day after surgery. Visual analog scale (0-10 VAS) and it was categorized using the following terms : no pain (0), mild (1-3), moderate (4-6), severe (7-9), or worse pain.

    On the 2nd day after surgery

  • VAS-pain after discharge

    VAS-pain on the 2nd day after discharge. Visual analog scale (0-10 VAS) and it was categorized using the following terms : no pain (0), mild (1-3), moderate (4-6), severe (7-9), or worse pain.

    On the 2nd day after discharge

  • Blood loss during surgery

    Blood loss during surgery in ml

    During the intervention

  • Procalcitonin

    Procalcitonin level in the blood in ng/mL

    On the 2nd day after surgery

  • C-reactive protein

    C-reactive protein in the blood in mg/L (Less than less than 3 mg/L consider be normal)

    On the 2nd day after surgery

  • ESR

    Erythrocyte sedimentation rate in mm/hr. Normal ESR ; \<20mm/hr.

    On the 2nd day after surgery

  • White blood cells

    White blood cells. The normal number of WBCs in the blood is 4.5 to 11.0 × 109/L.

    On the 2nd day after surgery

  • Hemoglobin

    Hemoglobin level in grams per deciliter. Normal hemoglobin for men ranges from 13.5 to 17.5 g/dL. Normal range for women is 12.0 to 15.5 g/dL.

    On the 2nd day after surgery

Study Arms (1)

Posterial approach

EXPERIMENTAL

All patients with spondilodiscitis admitted to surgical treatment in one center. During the operation, a posterior approach was used to access the source of infection. The incision of the skin, subcutaneous fat, and aponeurosis was made with the patient in the prone position, projecting through the spinous processes of the vertebrae above the infection site and one adjacent vertebra.

Procedure: Posterior approach to infection site

Interventions

For the posterior approach, an incision through the skin, subcutaneous fat, and aponeurosis was made with the patient in the prone position, projecting through the spinous processes of the vertebrae above the infection site and one adjacent vertebra. In all cases, a thorough exploration and debridement of the infection site was performed. Bone biopsies were taken from suspected infection sites in all patients for culture.

Posterial approach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- a deep infection affecting intervertebral discs and adjacent vertebral bodies in thoracolumbar spine region which were classified as B.3.1-2 and C2-C4 according to the Pola classification

You may not qualify if:

  • cervical spine region infection
  • unwilling to participate in the study,
  • patients with SD of a specific etiology
  • patients who received only conservative treatment,
  • patients with intradural infections.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal Center of Traumatology, Orthopedics and Arthroplasty

Cheboksary, Chuvashskaya Respublika, 428020, Russia

Location

MeSH Terms

Conditions

DiscitisSpondylitisOsteomyelitis

Condition Hierarchy (Ancestors)

Bone Diseases, InfectiousInfectionsBone DiseasesMusculoskeletal DiseasesSpinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Patients were informed about the upcoming surgery and its outcome - healing from infection. However, due to a lack of specialized medical training, they were unable to evaluate the use of the posterior approach. Outcome assessments were conducted without mentioning the use of the operative approach.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Patients with a deep infection affecting intervertebral discs and neighboring vertebral bodies in the thoracolumbar spine area, which were categorized as B.3.1-2 and C2-C4 according to the Pola classification.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2025

First Posted

January 20, 2026

Study Start

January 1, 2019

Primary Completion

January 1, 2023

Study Completion

January 1, 2023

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Locations